Previously, we reported that PPS has a stronger significance on OS than PFS in patients with NSCLC harboring sensitizing epidermal growth factor receptor (EGFR) mutations treated with first-line EGFR-TKIs. Here, EGFR is linked to non-small cell lung carcinoma.